Loading
Total declarations
Company
▲ Purchases (14 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Sept 2024 for Serina Therapeutics, Inc., €35k.
Filing timeline
BuySaleSteven Mintz
Insider track record
Disclosed buys
14
Disclosed sells
0
Signal history
Closed purchases
Market purchases
4
Positive at T+90
0%
Median T+90
-26.9%
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -22.1%Entry US$6.06 · Close at T+365 US$4.72
- -37.0%Entry US$8.25 · Close at T+365 US$5.20
- -35.7%Entry US$9.58 · Close at T+365 US$6.16
- -40.0%Entry US$9.84 · Close at T+365 US$5.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Steven Mintz: trading record in brief
Steven Mintz is a declared insider of Serina Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 17 May 2024 and 12 September 2024, the trades on record add up to 14 filings.
No open-market sale appears; the market trades are 14 purchases worth €266k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
In size, the median ticket on the buying side is €11k. On 14 out of 14 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -26.9%. This is a record of the past, not a forecast.
The record was last updated on 16 September 2024 with an open-market purchase (€35k) in Serina Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Steven Mintz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
6,000 shares@ US$6.46938.1% of flowCommon StockSEC:0001493152-24-036461:0
Canonical exit: 11 Dec 2024 (T+90)
1,350 shares@ US$6.58938.8% of flowCommon StockSEC:0001493152-24-033195:0
Canonical exit: 13 Nov 2024 (T+90)
5,000 shares@ US$9.5048.3% of flowCommon StockSEC:0001493152-24-025498:0
Canonical exit: 19 Sept 2024 (T+90)
554 shares@ US$8.504.7% of flowCommon StockSEC:0001493152-24-021176:0
Canonical exit: 15 Aug 2024 (T+90)
4 of 4 declarations
